Mtech Access are exhibiting at ISPOR in Europe
October 15, 2024 | Delta Hat, HEOR, Health Economics, ISPOR Europe, Market Access, Mtech Access, Petauri, ispor
• Mtech Access – Powered by Petauri™ are excited to be returning to ISPOR Europe this November. The team will be joined by colleagues from across Petauri, including Delta Hat
• Mtech Access and Petauri are inviting ISPOR delegates to come by stand 1406 to explore the latest trends in HEOR and discover how the Petauri platform can maximise your product’s potential and secure its place in the market
• The group will also be presenting 15 posters – one of which is a Top 5% Finalist for the ISPOR Europe 2024 Research Presentation Awards
Barcelona, Spain, 18th–20th November 2024: Mtech Access – Powered by Petauri are delighted to announce that they will be exhibiting at the ISPOR Europe conference in Barcelona over the 18th–20th November 2024. Mtech Access experts will be joined on stand 1406 by colleagues from across the Petauri platform, including Petauri Evidence and Delta Hat.
The team are inviting Pharmaceutical and Medical Device companies to meet them at booth 1406. Visitors to the stand are invited to put their questions to Mtech Access experts, and those who book a meeting in advance will benefit from:
- Dedicated time with the most relevant experts, who will discuss your challenges and opportunities
- A structured agenda for the conversation targeting your areas of focus
- Market and disease area-specific resources and insights
- 1 hour of free consultancy with their expert team, redeemable after the conference
To arrange a time to meet, complete this form or email info@mtechaccess.co.uk.
At the Mtech Access – Powered by Petauri booth at ISPOR, attendees will find insights from thought leaders from across the Petauri platform, with posters showcasing our latest thought leadership in market access and HEOR. Alongside our posters with clients, the Mtech Access, Delta Hat, and Petauri teams will be presenting 15 independent research posters. The poster ‘The Evolving Influence of the Inflation Reduction Act and Value Assessment in US Payer Decision-Making’, authored by the Petauri Evidence and Petauri Advisors teams, has been selected as a Top 5% Finalist for the ISPOR Europe 2024 Research Presentation Awards.
“We are delighted to be attending the ISPOR conference alongside our Petauri colleagues. We are eager to make new connections, reconnect with old friends, and forge lasting partnerships during this exciting event. We are particularly looking forward to exploring key themes in the HEOR space, such as European HTA challenges, US payer preferences, and technical breakthroughs including the use of AI in evidence synthesis.” – Lydia Crowe, Commercial Director.
About Petauri
With a team of industry experts boasting decades of practical and real-world experience, Petauri offer unparalleled expertise in global market access, evidence-based value demonstration, and HEOR. This powerful collaboration positions our clients to effectively navigate complex reimbursement landscapes, optimise market access strategies, and ensure successful national, regional, and local approval and uptake. Together, we are committed to maximising your product’s potential and securing its place in the market.
This content was provided by Petauri Evidence